PCSK9 inhibition in patients with acute stroke and symptomatic intracranial atherosclerosis: protocol for a prospective, randomised, open-label, blinded end-point trial with vessel-wall MR imaging.
BMJ Open
; 12(4): e060068, 2022 04 29.
Article
in En
| MEDLINE
| ID: mdl-35487727
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Intracranial Arteriosclerosis
/
Brain Ischemia
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Stroke
/
Plaque, Atherosclerotic
/
Ischemic Stroke
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Aspects:
Ethics
Limits:
Humans
Language:
En
Journal:
BMJ Open
Year:
2022
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Reino Unido